000 01405 a2200421 4500
005 20250513042406.0
264 0 _c19950622
008 199506s 0 0 eng d
022 _a1079-5642
024 7 _a10.1161/01.atv.15.4.495
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Amsterdam, R G
245 0 0 _aSynthetic analogues of the antithrombin III-binding pentasaccharide sequence of heparin. Prediction of in vivo residence times.
_h[electronic resource]
260 _bArteriosclerosis, thrombosis, and vascular biology
_cApr 1995
300 _a495-503 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntithrombin III
_xchemistry
650 0 4 _aBinding Sites
650 0 4 _aCarbohydrate Sequence
650 0 4 _aHalf-Life
650 0 4 _aHeparin
_xblood
650 0 4 _aKidney
_xmetabolism
650 0 4 _aLiver
_xmetabolism
650 0 4 _aMale
650 0 4 _aMolecular Sequence Data
650 0 4 _aMolecular Structure
650 0 4 _aOligosaccharides
_xblood
650 0 4 _aRats
650 0 4 _aRats, Wistar
700 1 _aVogel, G M
700 1 _aVisser, A
700 1 _aKop, W J
700 1 _aBuiting, M T
700 1 _aMeuleman, D G
773 0 _tArteriosclerosis, thrombosis, and vascular biology
_gvol. 15
_gno. 4
_gp. 495-503
856 4 0 _uhttps://doi.org/10.1161/01.atv.15.4.495
_zAvailable from publisher's website
999 _c7749231
_d7749231